TYRO3 and hepatocellular carcinoma: Using a comparative proteomics approach in HCC cells we identified TYRO3, a member of the TYRO3, AXL and MER (TAM) family of receptor tyrosine kinases (RTKs), as a driver of acquired sorafenib-resistance (SR) [14].